Barbara Carnemolla

Title: Barbara Carnemolla: Innovator in Antibody Research

Introduction

Barbara Carnemolla is a distinguished inventor based in Genoa, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and their applications in treating various medical conditions. With a total of six patents to her name, her work has had a profound impact on medical research and treatment methodologies.

Latest Patents

Among her latest patents is the invention titled "Antibodies of the ED-B domain of fibronectin, their construction and uses." This invention provides a specific binding member that targets the ED-B oncofoetal domain of fibronectin. It also outlines materials and methods for producing such binding members. Another notable patent is "Compositions and methods for treatment of angiogenesis in pathological lesions." This invention focuses on treating lesions associated with pathological angiogenesis, including tumors and other conditions such as rheumatoid arthritis and diabetic retinopathy. The patent describes a conjugate that combines a biocidal or cytotoxic molecule with an antibody directed against extracellular matrix components present in these lesions.

Career Highlights

Barbara has worked with prominent companies in the biotechnology sector, including Philogen S.p.a. and Bayer Schering Pharma AG. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the medical field.

Collaborations

Throughout her career, Barbara has collaborated with notable professionals, including Luciano Zardi and Dario Neri. These collaborations have further enriched her research and development efforts.

Conclusion

Barbara Carnemolla is a pioneering inventor whose work in antibody research has opened new avenues for medical treatment. Her patents reflect her commitment to advancing healthcare through innovative solutions.